Search Results
Ryan Benton Discusses Stem Cell Therapy for Duchenne’s Muscular Dystrophy – Video
By LizaAVILA
Ryan Benton Discusses Stem Cell Therapy for Duchenne #39;s Muscular Dystrophy
Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne #39;s muscular dystrophy...
By: http://www.cellmedicine.com
Read the original:
Ryan Benton Discusses Stem Cell Therapy for Duchenne's Muscular Dystrophy - Video
Stem Cell Therapy: Dr. Roberta Shapiro – A NY Physician’s Path to Panama – Video
By raymumme
Stem Cell Therapy: Dr. Roberta Shapiro - A NY Physician #39;s Path to Panama
Special Guest Speaker, Roberta F. Shapiro DO, FAAPM R speaks about: A New York Doctor #39;s Path to Panama at the Stem Cell Institute #39;s Stem Cell Therapy Publi...
By: http://www.cellmedicine.com
Read the original:
Stem Cell Therapy: Dr. Roberta Shapiro - A NY Physician's Path to Panama - Video
Stem Cell Therapy for Multiple Sclerosis: Ron McGill – Video
By JoanneRUSSELL25
Stem Cell Therapy for Multiple Sclerosis: Ron McGill
Ron McGill suffers from relapsing-remitting multiple sclerosis. He was started experiencing symptoms in 2009 but was not diagnosed with MS until January of 2013. He received several infusion...
By: http://www.cellmedicine.com
Excerpt from:
Stem Cell Therapy for Multiple Sclerosis: Ron McGill - Video
Stem Cell Therapy || Heart Failure || Stem Cell Treatment …
By NEVAGiles23
Heart Disease
With respect to the heart, stem cells have the ability to not only home into the damaged areas but also to initiate a cascade of biological events which both culminate in healing of the heart muscle. For example, animal studies have demonstrated that stem cell therapy will cause new muscle cells to be formed through stimulation of dormant stem cells that are already inside the heart muscle. In these studies, the administered stem cell also transformed into new heart muscle cells.
At Stem Cell Institute, our stem cell treatment protocol for heart failure involves administration of mesenchymal stem cells harvested from human umbilical cord tissue.
The adult stem cells used to treat heart failure at the Stem Cell Institute come from human umbilical cord tissue (allogeneic mesenchymal). These stem cells are expanded at Medistem Panamas state-of-the-art laboratory.
The mesenchymal stem cells we use are recovered from donated umbilical cords following normal, healthy births. Each mother has her medical history screened and is tested for infectious diseases. Proper consent is received from each family prior to donation.
All umbilical cord-derived stem cells are screened for infectious diseases to International Blood Bank Standards before they are cleared for use in patients.
Approximately 1 in 10 donated umbilical cords pass our rigorous screening process.
Through retrospective analysis of our cases, weve identified proteins and genes that allow us to screen several hundred umbilical cord donations to find the ones that we know are most effective. We only use these cells and we call them golden cells.
We go through a very high throughput screening process to find cells that we know have the best anti-inflammatory activity, the best immune modulating capacity, and the best ability to stimulate regeneration.
Read more here:
Stem Cell Therapy || Heart Failure || Stem Cell Treatment ...
Stem Cell Therapy || Spinal Cord Injury || Investigational …
By raymumme
Spinal Cord Injury
Damage to the spinal cord usually results in impairments or loss of muscle movement, muscle control, sensation and body system control.
Presently, post-accident care for those who suffer spinal cord injuries focuses on extensive physical therapy, occupational therapy, and other rehabilitation therapies; teaching the injured person how to cope with their disability.
A number of published papers and case studies support the feasibility of treating spinal cord injury with allogeneic human umbilical cord tissue-derived stem cells and autologous bone marrow-derived stem cells.
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report co-authored by Stem Cell Institute Founder Dr. Neil Riordan references many of them. Published improvements include improved ASIA scores, improved bladder and/or bowel function, recovered sexual function, and increased muscle control.
The adult stem cells used in spinal cord injury investigational treatments at the Stem Cell Institute come from two sources: the subjects own bone marrow (autologous mesenchymal and CD34+) and human umbilical cord tissue (allogeneic mesenchymal).
A licensed anesthesiologist harvests bone marrow from both hips under light general anesthesia in a hospital operating room. This procedure takes about 1 1/2 2 hours. Before they are administered to the subject, these bone marrow-derived stem cells must pass testing for quality, bacterial contamination (aerobic and anaerobic) and endotoxin.
All donated umbilical cords are screened for viruses and bacteria to International Blood Bank Standards.
Our stem cell clinical protocol for spinal cord injury calls for a total of 16 injections over the course of 4 weeks.
View original post here:
Stem Cell Therapy || Spinal Cord Injury || Investigational ...
Spinal cord injury and stem cell publications
By NEVAGiles23
Scientific publications from PubMed.gov
PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Regen Med. 2013 May;8(3):271-81 Authors: Ning G, Tang L, Wu Q, Li Y, Li Y, Zhang C, Feng S
Abstract AIM: We aim to explore the repair mechanism after the transplantation of CD34(+) human umbilical cord blood cells (HUCBCs) in traumatic spinal cord injury (SCI) in rats.
MATERIALS & METHODS: Wistar rats with SCI were randomly divided into three groups: DMEM injection (group A); CD34(+) HUCBC transplantation on the first day after injury (group B); and CD34(+) HUCBC transplantation on the sixth day after injury (group C). The Basso, Beattie and Bresnahan scores were used to evaluate motor behavior. At the injured site, the infarct size, blood vessel density, and survival and neural differentiation of transplanted cells were analyzed.
RESULTS: It was found that the Basso, Beattie and Bresnahan score in group B was significantly higher than other groups (p < 0.05), and the infarct size and blood vessel density at the injured site were significantly different (p < 0.01). However, the transplanted cells survived at least 3 weeks at the injured site, but did not differentiate into neural cells.
CONCLUSION: These results suggested transplantation of CD34(+) HUCBCs during the acute phase could promote the functional recovery better than during the subacute phase after SCI by raising blood vessel density, suggesting the possible clinical application for the treatment of spinal injury.
PMID: 23627822 [PubMed - indexed for MEDLINE]
Cytotherapy. 2013 Feb;15(2):185-91 Authors: Liu J, Han D, Wang Z, Xue M, Zhu L, Yan H, Zheng X, Guo Z, Wang H
Abstract BACKGROUND AIMS: The purpose of this study was to observe the clinical effect and safety of umbilical cord mesenchymal stem cells (UC-MSCs) in treating spinal cord injury (SCI) by intrathecal injection.
See the original post:
Spinal cord injury and stem cell publications
Stem Cell Therapy for Autism || Treatment Information …
By raymumme
Autism Protocol
Current investigative therapies for autism attempt to reverse these abnormalities through administration of antibiotics, antiinflammatory agents, and hyperbaric oxygen. Unfortunately, none of these approaches address the root causes of oxygen deprivation and intestinal inflammation.
Mesenchymal stem cells can regulate the immune system. It is thought that they may help to reverse inflammatory conditions and is currently in the final stages of clinical trials in the US for Crohns disease, a condition resembling the gut inflammation in autistic children.
Through administration of mesenchymal stem cells, we have observed improvement in subjects to whom weve administered stem cells at our facilities. The biological basis for our scientists appears in a peer-reviewed publication Journal of Translational Medicine: Stem Cell Therapy for Autism.
The adult stem cells used in the autism clinical investigation at the Stem Cell Institute come from human umbilical cord tissue (allogeneic mesenchymal). These stem cells are recovered from donated umbilical cords. Before they are approved for use, all umbilical cord-derived stem cells are screened for viruses and bacteria to International Blood Bank Standards. In some cases, we also utilize stem cells harvested from the subjects own bone marrow. Umbilical cord-derived stem cells are ideal for the autism protocol because they allow our physicians to administer uniform doses and they do not require any stem cell collection from the subject, which for autistic children and their parents, can be an arduous process. Because they are collected right after (normal) birth, umbilical cord-derived cells are much more potent than their older counterparts like bone marrow-derived cells for instance. Cord tissue-derived mesenchymal stem cells pose no rejection risk because the body does not recognize them as foreign.
Because HUCT stem cells are less mature than other cells, the bodys immune system is unable to recognize them as foreign and therefore they are not rejected. Weve performed thousands of procedures with umbilical cord stem cells and there has never been a single instance of rejection. HUCT stem cells also proliferate/differentiate more efficiently than older cells, such as those found in the bone marrow and therefore, they are considered to be more potent.
The umbilical cord-derived stem cells are administered intravenously by a licensed physician.
Below is an example of a typical autism schedule. Our investigational clinical protocol for autism (www.clinicaltrials.gov NCT02192749) has been approved by the National Institutional Review Board for Clinical Protocols.
Proper follow-up is an essential part of the autism clinical investigation process. Our primary goal is to ensure that your child is progressing safely. Regular follow-up also enables us to evaluate efficacy and improve our autism clinical protocols based on observed outcomes.
Continue reading here:
Stem Cell Therapy for Autism || Treatment Information ...
TRAGIC STORY! Paid $25,000 for Stem Cells @ Hospital Angeles Tijuana www.RegenerativeMedicine.mx – Video
By daniellenierenberg
TRAGIC STORY! Paid $25,000 for Stem Cells @ Hospital Angeles Tijuana http://www.RegenerativeMedicine.mx
TWO Websites: http://www.regenerativemedicinemx.com AND http://www.regenerativemedicinetijuana.com STEM CELL Resources: http://www.cellmedicinesociety.org/component/content/article/86-news/410-mex...
By: KyaLarae
Read the original post:
TRAGIC STORY! Paid $25,000 for Stem Cells @ Hospital Angeles Tijuana http://www.RegenerativeMedicine.mx - Video
Stem Cell Therapy || Spinal Cord Injury Treatment || Stem …
By Dr. Matthew Watson
Spinal Cord Injury
Damage to the spinal cord usually results in impairments or loss of muscle movement, muscle control, sensation and body system control.
Presently, post-accident care for spinal cord injury patients focuses on extensive physical therapy, occupational therapy, and other rehabilitation therapies; teaching the injured person how to cope with their disability.
A number of published papers and case studies support the feasibility of treating spinal cord injury with allogeneic human umbilical cord tissue-derived stem cells and autologous bone marrow-derived stem cells.
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report co-authored by Stem Cell Institute Founder Dr. Neil Riordan references many of them. Published improvements include improved ASIA scores, improved bladder and/or bowel function, recovered sexual function, and increased muscle control.
The adult stem cells used to treat spinal cord injuries at the Stem Cell Institute come from two sources: the patients own bone marrow (autologous mesenchymal and CD34+) and human umbilical cord tissue(allogeneic mesenchymal).
A licensed anesthesiologist harvests bone marrow from both hips under light general anesthesia in a hospital operating room. This procedure takes about 1 1/2 2 hours. Before they are administered to the patient, these bone marrow-derived stem cells must pass testing for quality, bacterial contamination (aerobic and anaerobic) and endotoxin.
All donated umbilical cords are screened for viruses and bacteria to International Blood Bank Standards.
Our stem cell treatment protocol for spinal cord injury calls for a total of 16 injections over the course of 4 weeks.
Originally posted here:
Stem Cell Therapy || Spinal Cord Injury Treatment || Stem ...
Sam Harrell’s Stem Cell Journey: Stem Cell Therapy for Multiple Sclerosis – Video
By LizaAVILA
Sam Harrell #39;s Stem Cell Journey: Stem Cell Therapy for Multiple Sclerosis
Sam Harrell sent us this homemade video documenting his progress from 2010 until now (2014). Sam was coaching football at Ennis high school in Texas when MS ...
By: http://www.cellmedicine.com
Go here to read the rest:
Sam Harrell's Stem Cell Journey: Stem Cell Therapy for Multiple Sclerosis - Video
Stem Cell Therapy for Spinal Cord Injury: Jamie Richie discusses her improvements – Video
By daniellenierenberg
Stem Cell Therapy for Spinal Cord Injury: Jamie Richie discusses her improvements
Jamie Richie discussed her treatments and improvements while undergoing her third round of stem cell therapy at the Stem Cell Institute in Panama City, Panam...
By: http://www.cellmedicine.com
View post:
Stem Cell Therapy for Spinal Cord Injury: Jamie Richie discusses her improvements - Video
ICMS International Cell Medicine Society
By Dr. Matthew Watson
T he International Cellular Medicine Society (ICMS) is an international non-profit dedicated to patient safety through strict evaluation of protocols and rigorous oversight of clinics and facilities engaged in the translation of point-of-care cell-based treatments.As a Professional Medical Association, the ICMS represents Physiciansand Researchersfrom over 35 countries who share a mission to provide Scientifically Credible and Medically Appropriate Treatments to Informed Patients.Join the ICMS.
The ICMS Works Tirelessly for the Clincial Translation of Field of Cell-Based Point-of-Care Treatments through:
Comprehensive Medical Standards and Best Practice Guidelines for Cell Based Medicine,
Strict Evaluation and Rigerous Oversight of Stem Cell Clinics and Facilities through aGlobal Accreditation Process,
Physician Education through daily updates on the latest Research on Stem Cells, the monthly Currents In Stem Cell Medicine and the annual International Congress for Regenerative and Stem Cell Medicine.
Join the ICMSto receive the latest news and research from cell-based medicne, including the bi-monthly publication, Currents in Stem Cell Medicine.
Read more from the original source:
ICMS International Cell Medicine Society
Stem Cell Therapy for Traumatic Brain Injury – Video
By raymumme
Stem Cell Therapy for Traumatic Brain Injury
Oswaldo Tapenes received multiple injections of human umbilical cord-derived mesenchymal stem cells and his own bone marrow-derived stem cells over the cours...
By: http://www.cellmedicine.com
Read more from the original source:
Stem Cell Therapy for Traumatic Brain Injury - Video
Heart Failure Patient Has 3 Normal EKGs After Stem Cell Therapy – Video
By raymumme
Heart Failure Patient Has 3 Normal EKGs After Stem Cell Therapy
I was diagnosed 20 years ago. My heart was stopped up. I have 11 stents in my heart. When they put in (stents) nine, ten and eleven they blocked an artery an...
By: http://www.cellmedicine.com
Read the rest here:
Heart Failure Patient Has 3 Normal EKGs After Stem Cell Therapy - Video
Stem Cells | ICMS — Advancing Stem Cell Treatments, Stem Cell …
By LizaAVILA
T he International Cellular Medicine Society (ICMS) is an international non-profit dedicated to patient safety through strict evaluation of protocols and rigorous oversight of clinics and facilities engaged in the translation of point-of-care cell-based treatments.As a Professional Medical Association, the ICMS represents Physiciansand Researchersfrom over 35 countries who share a mission to provide Scientifically Credible and Medically Appropriate Treatments to Informed Patients.Join the ICMS.
The ICMS Works Tirelessly for the Clincial Translation of Field of Cell-Based Point-of-Care Treatments through:
Comprehensive Medical Standards and Best Practice Guidelines for Cell Based Medicine,
Strict Evaluation and Rigerous Oversight of Stem Cell Clinics and Facilities through aGlobal Accreditation Process,
Physician Education through daily updates on the latest Research on Stem Cells, the monthly Currents In Stem Cell Medicine and the annual International Congress for Regenerative and Stem Cell Medicine.
Join the ICMSto receive the latest news and research from cell-based medicne, including the bi-monthly publication, Currents in Stem Cell Medicine.
Read more:
Stem Cells | ICMS -- Advancing Stem Cell Treatments, Stem Cell ...
Professor Arnold Caplan discusses mesenchymal stem cell therapy for multiple sclerosis – Video
By Sykes24Tracey
Professor Arnold Caplan discusses mesenchymal stem cell therapy for multiple sclerosis
Professor Caplan is "The father of the mesenchymal stem cell (MSC)". In this clip, he describes a mouse experiment using human MSCs in a mouse model of MS. T...
By: http://www.cellmedicine.com
Follow this link:
Professor Arnold Caplan discusses mesenchymal stem cell therapy for multiple sclerosis - Video
Stem Cell Therapy for Knees, Osteoarthritis and Autoimmune Disorders: King Goff Discusses Treatment – Video
By Sykes24Tracey
Stem Cell Therapy for Knees, Osteoarthritis and Autoimmune Disorders: King Goff Discusses Treatment
King Goff received three applications of his own adipose tissue-derived stem cells over the course of 3 days for a knee injury and autoimmune issues at the S...
By: cellmedicine
See more here:
Stem Cell Therapy for Knees, Osteoarthritis and Autoimmune Disorders: King Goff Discusses Treatment - Video
Jorge Paz MD: Adult Stem Cell Therapy for Arthritis, Sports Injury, and Autoimmune Disease || 3 of 3 – Video
By LizaAVILA
Jorge Paz MD: Adult Stem Cell Therapy for Arthritis, Sports Injury, and Autoimmune Disease || 3 of 3
Stem cell therapy for osteoarthritis using adipose (fat) stem cell. Case study of 76 year-old man with osteoarthritis in his knees. Stromal vasular fraction treatment statistics including side effects collected over 800 infusions. Stem cell treatments for sports injuries and why pro sports stars are seeking treatment. Case study of a professional dancer with knee and neck problems who returned to competition after stem cell treatment in Panama.
By: cellmedicine
Go here to see the original:
Jorge Paz MD: Adult Stem Cell Therapy for Arthritis, Sports Injury, and Autoimmune Disease || 3 of 3 - Video
A proposed 6-step platform for the cell therapy industry to consider in combating non-compliant cell therapy treatments
By Dr. Matthew Watson
Further to my recent post, "Six steps to fighting non-compliant cell therapy treatments. The stuff of grey shades, spades, ivory towers and (ahem) balls.", I have crafted a 6-point platform that I propose to submit (with potential edits based on preliminary feedback) to several of the leading industry and professional organizations for their consideration including ARM, ISCT, ISSCR, FACT, AABB ICMS, and perhaps, in due course, to patient groups, physician groups, disease-specific professional organizations (e.g, cardiology, oncology, neurology, cosmetic, etc).
I welcome comments and feedback.
1. In addition to helping patients distinguish between compliant and non-compliant treatments (and providers) we must do more to help patients distinguish between non-compliant cell therapy treatments (and providers) which are more or less risky.
2. Whatever we do in response to this issue should be done with an eye to being practical and helpful to patients in the real-life context of their decision about whether or not to buy a non-complaint cell therapy.
3. Our response to this issue should be based on a risk-based approach recognizing that not all non-compliance is created equal. We should create a framework for risk-based analysis (both for us and our audiences) and focus initiatives around those which present the highest risk.
4. We recognize the problem of non-compliant cell therapies is not just a problem that exists in jurisdictions with little, no, or poor regulation but that is a growing problem even in the most highly regulated jurisdictions meaning the solution cannot be regulated it depends on education and enforcement.
5. We recognize regulatory agencies cannot enforce non-compliance on their own. We as an industry need to complement their efforts through our own standards and enforcement.
6. Stakeholder groups should support the formation of a multi-organizational initiative to, based on a risk-based assessment, spotlight the categories or signs of highest-risk offenders for use by patients and/or their physicians in identifying whether or not treatments (and providers) they may be considering fall into the that category associated with the highest level of risk.
What do you think?
Six steps to fighting non-compliant cell therapy treatments. — The stuff of grey shades, spades, ivory towers and (ahem) balls.
By Dr. Matthew Watson
Today an article entitled "Professors Critique Stem Cell Medical Tourism" appeared in the online version of The Harvard Crimson summarizing a recent panel discussion hosted in least in part by Harvard Law School assistant professor I. Glenn Cohen and University of Alberta law professor Timothy Caulfield. The article concludes thusly:
The panelists emphasized that more accurate information should be provided to the public regarding stem cell treatments.
In addition to helping patients distinguish between compliant and non-compliant treatments (and providers) there are a lot of ways to help patients distinguish between non-compliant cell therapy treatments (and providers) which are more or less risky.
Let me use examples.
In between - in my opinion - are clinics like Stem Cell Institute and StemCellMD.
___